Zobrazeno 1 - 7
of 7
pro vyhledávání: '"C.D.A. (Coen) Stehouwer"'
Autor:
Griët Bos, J.M. Dekker, R.J. Heine, C.D.A. (Coen) Stehouwer, Pieter J. Kostense, Lex M. Bouter, Giel Nijpels, Annemarie Becker
Publikováno v:
Journal of Internal Medicine, 253(3), 293-300. Wiley-Blackwell
Becker, A, Kostense, P J, Bos, G, Heine, R J, Dekker, J M, Nijpels, G, Bouter, L M & Stehouwer, C D A 2003, ' Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes ', Journal of Internal Medicine, vol. 253, no. 3, pp. 293-300 . https://doi.org/10.1046/j.1365-2796.2003.01113.x
Becker, A, Kostense, P J, Bos, G, Heine, R J, Dekker, J M, Nijpels, G, Bouter, L M & Stehouwer, C D A 2003, ' Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes ', Journal of Internal Medicine, vol. 253, no. 3, pp. 293-300 . https://doi.org/10.1046/j.1365-2796.2003.01113.x
Objectives. Amongst nondiabetic individuals, a high serum homocysteine concentration is an independent but relatively weak risk factor for coronary events. However, it is not known whether homocysteine increases risk of coronary events in type 2 diab
Publikováno v:
Expert Opinion on Pharmacotherapy. 2:1449-1460
Elevated fasting plasma concentrations of homocysteine have a high prevalence in subjects with cardiovascular disease and have also been associated with an increased risk of atherothrombosis in most, but not all, prospective studies. The most frequen
Autor:
Giel Nijpels, Lex M. Bouter, Cornelis Jakobs, C.D.A. (Coen) Stehouwer, Jacqueline M. Dekker, Robert J. Heine, Pieter J. Kostense, Ellen K. Hoogeveen
Publikováno v:
Circulation, 101, 1506-1511. American Heart Association
Scopus-Elsevier
Hoogeveen, E K, Kostense, P J, Jakobs, C A J M, Dekker, J M, Nijpels, M G A A M, Heine, R J, Bouter, L M & Stehouwer, C D A 2000, ' Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. ', Circulation, vol. 101, pp. 1506-1511 . https://doi.org/10.1161/01.cir.101.13.1506
Scopus-Elsevier
Hoogeveen, E K, Kostense, P J, Jakobs, C A J M, Dekker, J M, Nijpels, M G A A M, Heine, R J, Bouter, L M & Stehouwer, C D A 2000, ' Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. ', Circulation, vol. 101, pp. 1506-1511 . https://doi.org/10.1161/01.cir.101.13.1506
Background —A high serum total homocysteine (tHcy) concentration is a risk factor for death, but the strength of the relation in patients with type 2 (non–insulin-dependent) diabetes mellitus compared with nondiabetic subjects is not known. A cro
Publikováno v:
Seminars in Thrombosis and Hemostasis. 26:281-290
Hyperhomocysteinemia has been associated with premature atherothrombotic vascular disease. It is not known whether hyperhomocysteinemia induces a distinct type of vascular disease. Its interaction, if any, with traditional risk factors also remains u
Publikováno v:
Clinical Chemistry and Laboratory Medicine. 41
Several studies, some population-based, have plasma homocysteine levels linked to blood pressure, especially systolic pressure. In one large and carefully conducted epidemiological study, each 5 micromol/l increase in plasma homocysteine was associat
Autor:
B. M. Coull, David S. Siscovick, Edith J. M. Feskens, M. A. Gall, Robert Clarke, Egil Arnesen, G. Alfthan, Steven M. Schwartz, M. R. Law, D. W. Jacobsen, Lewis H. Kuller, Helmut Schulte, Per Magne Ueland, Ann E. Donald, R. W. Evans, P. Elwood, D. E. L. Wilcken, Pierre Ducimetière, Daan Kromhout, A. G. Shaper, A. Hofman, J. Pickering, C.D.A. (Coen) Stehouwer, J. M. Roseman, A. Von Eckardstein, Y. I. Lolin, M. L. Bots, J. Tuomilehto, Brian Fowler, Godfried H.J. Boers, Paul Sherliker, Arne Lindgren, S. A. A. Beresford, S Ebrahim, G Davey Smith, Monique M.B. Breteler, Sarah Lewington, D. E. Grobbee, Andrew G. Bostom, P. N. Hopkins, H. H. Parving, Nicholas J. Wald, Leslie Daly, Jaspal S. Kooner, Pieter J. Kostense, Killian Robinson, P. Jungers, Mohammad Azam Mansoor, J. Genest Jr, Ottar Nygård, Ellen K. Hoogeveen, Rory Collins, S. E. Vollset, S. Evers, Aaron R. Folsom, F. Parrot, Kaare H. Bønaa, John C. Chambers, Petra Verhoef, F. C. Luft, Jacques Blacher, Lars Brattström, M. R. Malinow, I. M. Graham, Peter H. Whincup, G. S. Omenn, Paul F. Jacques, Gerd Assmann, G. Freyburger, F. Loehrer, J. Ubbink, Ivan J. Perry, Helga Refsum, K. Dalery, P. Linksted, C. H. Hennekens, Jacob Selhub, Meir J. Stampfer
Publikováno v:
Scopus-Elsevier
CONTEXT: It has been suggested that total blood homocysteine concentrations are associated with the risk of ischemic heart disease (IHD) and stroke. OBJECTIVE: To assess the relationship of homocysteine concentrations with vascular disease risk. DATA
Autor:
Ellen K. Hoogeveen, C.D.A. (Coen) Stehouwer, Robert J. Heine, Albert J. C. Mackaay, Cornelis Jakobs, P.J. Beks, Lex M. Bouter, Pieter J. Kostense
Publikováno v:
Hoogeveen, E K, Kostense, P J, Beks, P J, Mackaay, A J C, Jakobs, C, Bouter, L M, Heine, R J & Stehouwer, C D A 1998, ' Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus-A population-based ', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 1, pp. 133-138 . https://doi.org/10.1161/01.ATV.18.1.133
Arteriosclerosis, Thrombosis, and Vascular Biology, 18(1), 133-138. Lippincott Williams and Wilkins
Arteriosclerosis, Thrombosis, and Vascular Biology, 18(1), 133-138. Lippincott Williams and Wilkins
Abstract —A high serum total homocysteine (tHcy) level is an independent risk factor for cardiovascular disease. Because it is not known whether the strength of the association between hyperhomocysteinemia and cardiovascular disease is similar for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace43749c88c88e4cec70bdcb4c633f1
https://research.vu.nl/ws/files/2895032/263643.pdf
https://research.vu.nl/ws/files/2895032/263643.pdf